COMPANION ANIMALS
Companion animal health is under pressure from rising antibiotic resistance, recurrent infections, and gut disruption. Discover INNOVA AMP PET — an innovative, veterinary‑guided solution that supports resilience, gut balance, and responsible antimicrobial stewardship.
Antibiotics are losing their edge
Across pets worldwide, bacteria like E. coli, Salmonella, and Staphylococcus are showing resistance rates that in some regions exceed 50%. This means more treatment failures, longer recovery times, and higher costs for owners and veterinarians.
Silent spreaders
Even healthy pets can carry resistant bacteria. For example, 5–6% of dogs may carry Salmonella, and a significant portion of those strains are multidrug‑resistant. These bacteria can pass to owners, creating a hidden public‑health risk.
Recurring infections
Chronic diarrhoea, ear infections, and skin conditions often return despite multiple antibiotic courses. This cycle frustrates owners, strains veterinary resources, and undermines trust in treatment
Gut health at risk
Antibiotics don’t just target pathogens — they disrupt the gut microbiota. The result: weaker immunity, digestive issues, and a higher chance of relapse.
Overuse accelerates resistance
Frequent or inappropriate antibiotic use perpetuates antimicrobial resistance, making standard infections harder to treat and reducing trust in conventional therapies
Why it matters
The real cost of antibiotic failure isn’t just the drug - it’s lost time, repeated visits, and declining trust
INNOVA AMP PET
A Smarter Solution
Nano‑encapsulated peptide technology engineered to strengthen resilience and support gut health in dogs and cats when used within veterinary‑led care plans.
_edited.png)
Supports gut health
helps maintain a balanced microbiota for stronger immunity
Stewardship‑focused
developed to fit One‑Health principles, supporting responsible antimicrobial use
Reduces recurrence risk
complements veterinary care to break the cycle of repeated infections
Easy integration
simple to administer, backed by professional documentation and safety data
INNOVA AMP PET is a next-generation peptide-based formulation developed for integration into companion animal management programs.
Powered by nano-encapsulated peptide technology, it is designed for use within structured veterinary and nutritional frameworks in environments where bacterial challenges are subject to clinical assessment and regulatory oversight.
Developed to align with responsible production and stewardship principles within modern veterinary practice.
For professional enquiries, dosing guidance, or to request study summaries and technical documentation, contact us on info@innovabiotechnology.com.
.png)